Cargando…
Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
BACKGROUND: Acute interstitial nephritis secondary to proton pump inhibitors (PPIs) frequently goes undiagnosed due to its subacute clinical presentation, which may later present as chronic kidney disease (CKD). We investigated the association of PPI use with the development of CKD and death. METHOD...
Autores principales: | Arora, Pradeep, Gupta, Anu, Golzy, Mojgan, Patel, Nilang, Carter, Randolph L., Jalal, Kabir, Lohr, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973085/ https://www.ncbi.nlm.nih.gov/pubmed/27487959 http://dx.doi.org/10.1186/s12882-016-0325-4 |
Ejemplares similares
-
Renal function, calcium regulation, and time to hospitalization of patients with chronic kidney disease
por: Golzy, Mojgan, et al.
Publicado: (2013) -
The MDRD equation underestimates the prevalence of CKD among blacks and overestimates the prevalence of CKD among whites compared to the CKD-EPI equation: a retrospective cohort study
por: Arora, Pradeep, et al.
Publicado: (2012) -
Pantoprazole, a proton pump inhibitor, increases orthodontic tooth movement in rats
por: Shirazi, Mohsen, et al.
Publicado: (2014) -
Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
por: Tomlinson, Laurie A., et al.
Publicado: (2017) -
Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease
por: Hughes, John, et al.
Publicado: (2018)